| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0098 | 0.8 |